Neuphoria TherapeuticsNEUP
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 22 institutions reported holding Neuphoria Therapeutics Inc. (NEUP) in their 13F filings, up 3 from Q1 2026. 6 opened new positions and 3 sold out. The largest holders were Lynx1 Capital Management LP ($3.8M), AdvisorShares Investments LLC ($1.1M) and Vanguard Capital Management LLC ($758K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Neuphoria Therapeutics Inc.
- CUSIP
- 64136E102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $423K |
| Exits | 3 | $362K |
All 13F filers, Q1 2026 → Q2 2026: 327,786 shares bought and 91,653 shares sold, net +236,133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Lynx1 Capital Management LP | 0.44% | No change | 875,328 | $3.8M |
| AdvisorShares Investments LLC | 0.13% | Add +62.8% | 252,909 | $1.1M |
| Vanguard Capital Management LLC | 0.00% | Add +76.1% | 173,488 | $758K |
| Shay Capital LLC | 0.08% | Add +3.2% | 155,822 | $681K |
| Balyasny Asset Management L.P. | 0.00% | Add +0.0% | 142,228 | $622K |
| Citadel Advisors | 0.00% | Add +275.4% | 72,559 | $317K |
| Geode Capital Management, LLC | 0.00% | Reduce -4.8% | 49,516 | $216K |
| Ikarian Capital, LLC | 0.03% | No change | 47,443 | $207K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.7% | 33,806 | $148K |
| ADAR1 Capital Management, LLC | 0.01% | No change | 30,000 | $131K |
| FNY Investment Advisers, LLC | 0.04% | No change | 26,500 | $115K |
| Renaissance Technologies | 0.00% | New | 25,500 | $111K |
| XTX Topco Ltd | 0.00% | New | 23,089 | $101K |
| HRT Financial LP | 0.00% | New | 22,865 | $99K |
| Jane Street Group, LLC | 0.00% | New | 14,903 | $65K |
| Boothbay Fund Management, LLC | 0.00% | No change | 14,000 | $61K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 11,222 | $49K |
| Northern Trust Corp. | 0.00% | New | 10,610 | $46K |
| Merck & Co., Inc. | 0.01% | No change | 10,027 | $44K |
| UBS Group AG | 0.00% | Reduce -8.6% | 2,117 | $9K |
| Morgan Stanley | 0.00% | No change | 58 | $254 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 3 | $13 |
"% of holder's portfolio" is NEUP's weight in each manager's 13F, not the share of Neuphoria Therapeutics Inc. the manager owns.